HR 5629·Federal·house
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
In CommitteeFiled Sep 30, 2025
Sponsor: Rep. Houchin, Erin [R-IN-9] (R)
Latest Action
Referred to the House Committee on Energy and Commerce.
Sep 30, 2025
Email me when HR 5629 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 5629. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Ask about HR 5629
3 free questions a day, no accountHearings
- Policies to Protect Our Communities From Illicit Drug ThreatsHouse Energy and Commerce Subcommittee on Health · Mar 26, 2026
History
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
Sponsors
- Rep. Houchin, Erin [R-IN-9] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 5629 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 5629 freeOr ask your AI assistant about HR 5629 directly:
Add to Claude, ChatGPT or Cursor